Appetite & fullness support
Semaglutide acts on the GLP-1 pathway involved in appetite and fullness. Your response and tolerability guide the plan.

Nx Lean Semaglutide
SemaglutidePackaging may vary. Compounded by a licensed pharmacy, not Nirvanix.
Weight care, with a clear plan
GLP-1 Weight Loss – Semaglutide (Low Dose)
A once-weekly GLP-1 injection, started at a low dose, to help make hunger easier to manage while you build habits that support your weight-loss goals.
Shipping: Free. Final total confirmed before payment.
Shipping is included.
State availability is temporarily unavailable. Please check again before starting.
Loading the selected option…
Online enrollment for this option is being prepared. Existing patients can manage their care.
It is how the product is listed. Semaglutide is usually started at a low weekly dose and raised step by step only as your body adjusts. Your clinician and pharmacy set the exact amount, concentration, and schedule for your prescription.
No. This is compounded semaglutide, prepared by a licensed pharmacy for each patient. It is not FDA-approved, and it is not a generic version of Wegovy or Ozempic. The study numbers on this page come from the FDA-approved injection.
That average came from 68 weeks of 2.4 mg weekly injections with lifestyle support. It does not establish results for this low-dose compounded option or predict your individual response.
Semaglutide acts on one hormone pathway, GLP-1. Tirzepatide acts on two, GLP-1 and GIP. In a head-to-head study of the approved injections at their top doses, tirzepatide led to more average weight loss. Your clinician can help you compare them for your health and goals.
There is no fixed response timeline for an individual. The cited study followed specific injectable doses for more than a year; it does not predict results for this preparation. Agree with your clinician on what to track and when to review your response.
Your evaluation should also consider nutrition, physical activity, sleep, and other factors affecting your weight and health.
Share its name, dose, schedule, last dose, and any side effects during the assessment. Your prescriber needs that information before recommending a change; do not overlap or convert treatments on your own.
Ask the dispensing pharmacy or prescriber to clarify the exact concentration, amount, and syringe markings before using it. A dose from a different vial or another person's prescription may not match yours.
Use the storage temperature, usable-life date, and handling instructions supplied by your dispensing pharmacy. Concentrations and preparations vary. Ask for clarification before injecting if the label or syringe measurement is unclear.
Semaglutide has important contraindications and side effects. Review these before starting.
This is a summary, not a complete prescribing guide. Read the information supplied with your prescription. For a severe allergic reaction or another medical emergency, call 911.
Sources & prescribing informationA closer look
Start with what this treatment is, why it may be considered, and what to discuss with your clinician.
Semaglutide acts on the GLP-1 pathway involved in appetite and fullness. Your response and tolerability guide the plan.
The listing is a low-dose option, in line with starting slowly. Use only the amount and schedule prescribed for you.
Combine treatment decisions with nutrition, movement, and follow-up focused on your health goals.
How it works
Semaglutide acts on GLP-1 receptors involved in appetite, fullness, and blood sugar. Its main weight-loss study raised the dose step by step to 2.4 mg a week, so a low-dose plan needs its own conversation about what to expect.
Explore the evidenceYour timeline
From your first assessment to follow-up, know what comes next. Your clinician sets the pace and the plan.
Complete an assessment covering your weight history, medications, health conditions, and goals.
A clinician assesses eligibility, formulation, alternatives, and any testing needed before a decision.
If prescribed, follow the exact pharmacy label and individual plan. Do not borrow a dosing schedule from another formulation.
Discuss progress and side effects at the follow-up interval set by your clinician. Dose changes depend on your response.
Care milestones are illustrative. Timing, testing, and treatment depend on your clinical review.
Personal care starts with context
A weight-care assessment looks beyond a number on the scale.
The evidence behind the conversation
Know what was studied, who took part, and how it relates to this option. Study findings are not a prediction of your results.
Semaglutide
86%
Lost at least 5% of their weight with weekly semaglutide injections[1]
Semaglutide
14.9%
Average weight reduction with 2.4 mg weekly injections[2]
Published study findings, not Nirvanix patient results. The studied formulation, dose, and population may differ from this offering. These figures do not establish the same outcomes for compounded preparations, other routes, or combination treatments. Individual results vary.
2.4 mg weekly for 68 weeks, versus 31.5% with placebo. Both groups received lifestyle support; the trial enrolled 1,961 adults with obesity or overweight without diabetes. Not evidence for a low-dose regimen or a compounded preparation.
STEP 1 · NEJM, 2021 (opens in a new tab)Semaglutide 2.4 mg injected weekly, after dose escalation, with lifestyle support for 68 weeks; 2.4% with placebo. This was not a low-dose trial and does not establish results for this compounded offering.
STEP 1 · NEJM, 2021 (opens in a new tab)What this means for this optionThese results do not establish outcomes for low-dose regimens or compounded preparations.
Read the source (opens in a new tab)What this means for this optionApproval and dosing instructions for the branded injection do not apply automatically to a compounded preparation.
Read the source (opens in a new tab)How we work
Choose a treatment and complete its assessment when enrollment is available.
Review your options, including any labs or video visit needed for a decision.
If prescribed, begin treatment and stay connected through your patient portal.

Personal care.
Part of your everyday.

The people behind Nirvanix
Our founder, Shane Ali, MD, is a board-certified emergency medicine physician. Meet the Nirvanix team and learn about our approach to care.
Meet the teamYour online clinician is assigned according to your treatment and state.
A little more clarity
Comparing costs or getting ready to start? Read our care FAQs.
Have a question about your own care? Sign in to your account.
It is how the product is listed. Semaglutide is usually started at a low weekly dose and raised step by step only as your body adjusts. Your clinician and pharmacy set the exact amount, concentration, and schedule for your prescription.
No. This is compounded semaglutide, prepared by a licensed pharmacy for each patient. It is not FDA-approved, and it is not a generic version of Wegovy or Ozempic. The study numbers on this page come from the FDA-approved injection.
That average came from 68 weeks of 2.4 mg weekly injections with lifestyle support. It does not establish results for this low-dose compounded option or predict your individual response.
Semaglutide acts on one hormone pathway, GLP-1. Tirzepatide acts on two, GLP-1 and GIP. In a head-to-head study of the approved injections at their top doses, tirzepatide led to more average weight loss. Your clinician can help you compare them for your health and goals.
There is no fixed response timeline for an individual. The cited study followed specific injectable doses for more than a year; it does not predict results for this preparation. Agree with your clinician on what to track and when to review your response.
Your evaluation should also consider nutrition, physical activity, sleep, and other factors affecting your weight and health.
Share its name, dose, schedule, last dose, and any side effects during the assessment. Your prescriber needs that information before recommending a change; do not overlap or convert treatments on your own.
Ask the dispensing pharmacy or prescriber to clarify the exact concentration, amount, and syringe markings before using it. A dose from a different vial or another person's prescription may not match yours.
Use the storage temperature, usable-life date, and handling instructions supplied by your dispensing pharmacy. Concentrations and preparations vary. Ask for clarification before injecting if the label or syringe measurement is unclear.
Your goals. Your next chapter.
Start with your history and a conversation about what matters to you.
State availability is temporarily unavailable. Please check again before starting.
Prefer an in-person visit? Explore our Austin clinic.